EyePoint, Inc. (EYPT) stock
EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$0.26−0.01 (-2.87%)
Close on Nov 19, 2026Market cap $22.78MP/E –Yield –
EyePoint net income
Net income is the profit left for shareholders after every expense, interest and tax.
EyePoint's net income for the twelve months ending Jun 30, 2026 was -$306.64M. For fiscal 2025 it was -$231.96M. The highest annual figure on record is $8.75M in fiscal 2010.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$231.96M | – |
| FY2024 | Dec 31, 2024 | -$130.87M | – |
| FY2023 | Dec 31, 2023 | -$70.80M | – |
| FY2022 | Dec 31, 2022 | -$102.25M | – |
| FY2021 | Dec 31, 2021 | -$58.42M | – |
| FY2020 | Dec 31, 2020 | -$45.39M | – |
| FY2018 | Jun 30, 2018 | -$53.17M | – |
| FY2017 | Jun 30, 2017 | -$18.49M | – |
| FY2016 | Jun 30, 2016 | -$21.55M | -439.5% |
| FY2015 | Jun 30, 2015 | $6.35M | – |
| FY2014 | Jun 30, 2014 | -$13.36M | – |
| FY2013 | Jun 30, 2013 | -$11.90M | – |
| FY2012 | Jun 30, 2012 | -$24.84M | – |
| FY2011 | Jun 30, 2011 | -$8.63M | -198.6% |
| FY2010 | Jun 30, 2010 | $8.75M | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$94.47M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$84.83M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$67.61M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$59.73M | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$59.43M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$45.20M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$41.40M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$29.36M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$30.83M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$29.28M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$14.10M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$12.61M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$22.92M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$21.16M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$43.45M | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$18.42M | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$19.41M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$20.98M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$19.43M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -$16.70M | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -$10.01M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$12.28M | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -$15.47M | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -$3.80M | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$12.95M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -$13.17M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$34.43M | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$6.98M | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$5.78M | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$5.98M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$6.12M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$5.14M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$67.00K | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$7.16M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$6.39M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -$5.04M | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | -$5.19M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | -$4.93M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | -$5.15M | – |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | -$5.00M | – |
See a number that looks wrong?